To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Service

The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of

The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analy

This Element explains how corporate financialization,through predatory value extraction, undermines investment in innovation in the US.